MARKET

LTRN

LTRN

Lantern Pharma Inc
NASDAQ
3.280
-0.030
-0.91%
After Hours: 3.330 +0.05 +1.52% 17:16 11/04 EST
OPEN
3.190
PREV CLOSE
3.310
HIGH
3.320
LOW
3.140
VOLUME
22.91K
TURNOVER
--
52 WEEK HIGH
11.99
52 WEEK LOW
2.740
MARKET CAP
35.31M
P/E (TTM)
-1.9922
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LTRN last week (1028-1101)?
Weekly Report · 19h ago
Press Release: Lantern Pharma to Report Third Quarter 2024 Operating & Financial Results on November 7th, 2024 at 4:30 p.m. ET
Dow Jones · 4d ago
Weekly Report: what happened at LTRN last week (1021-1025)?
Weekly Report · 10/28 11:32
Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2024
Barchart · 10/23 07:45
Weekly Report: what happened at LTRN last week (1014-1018)?
Weekly Report · 10/21 11:28
Lantern Pharma granted fast track designation for LP-184
TipRanks · 10/15 13:16
LANTERN PHARMA INC - PHASE 1B/2A TRIAL FOR RECURRENT GBM TO START LATE 2024
Reuters · 10/15 13:07
Weekly Report: what happened at LTRN last week (1007-1011)?
Weekly Report · 10/14 12:00
More
About LTRN
Lantern Pharma Inc. is an artificial intelligence (AI) company. The Company is developing targeted and transformative cancer therapies using its proprietary RADR AI and machine learning (ML) platform with multiple clinical-stage drug programs. Its proprietary AI and machine learning (ML) platform, RADR, leverages over 60 billion oncology-focused data points and a library of over 200 advanced ML algorithms to help solve problems in oncology drug development. It is engaged in the development of its pipeline of therapies that span multiple cancer indications, including both solid tumors and blood cancers and an antibody drug conjugate (ADC) program. It has active clinical programs for its three lead small molecule drug candidates: LP-300, LP-184, and LP-284. These programs are focused on multiple cancer indications, including both solid tumors and blood cancers. It is also focused on the clinical execution of its therapies for CNS and brain cancers through Starlight Therapeutics Inc.

Webull offers Lantern Pharma Inc stock information, including NASDAQ: LTRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LTRN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LTRN stock methods without spending real money on the virtual paper trading platform.